ASHLEY PEREL: Open Payments
NPI 1891575056 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 19 payments from 9 companies in 2025. Trend: 2023 $31 · 2024 $535 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Fennec Pharmaceuticals, Inc. | 1 | $202 |
| SCPHARMACEUTICALS INC. | 3 | $170 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| PFIZER INC. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Boston Scientific Corporation | 1 | $24 |
| CVRx, Inc. | 1 | $19 |
Products named: Fyarro, FUROSCIX, VERQUVO, LEQVIO, CAMZYOS, VYNDAQEL, ELIQUIS, JARDIANCE.
Industry payments across VA — which companies pay providers there.
